DNA repair is essential in maintaining genome integrity and defects in different steps of the process have been linked to cancer and aging. It is a long lasting question how DNA repair is spatially and temporarily organized in the highly compartmentalized nucleus and whether the diverse nuclear compartments regulate differently the efficiency of repair. Increasing evidence suggest the involvement of nuclear pore complexes in repair of double-strand breaks (DSBs) in yeast. Here, we show that the human nucleoporin 153 (NUP153) has a role in repair of DSBs and in the activation of DNA damage checkpoints. We explore the mechanism of action of NUP153 and we propose its potential as a novel therapeutic target in cancers.
INTRODUCTION
DNA double-strand breaks (DSBs) are particularly dangerous as their inefficient or inaccurate repair can result in mutations and chromosomal translocations that may induce cancer. 1 DSBs can be repaired by one of two major pathways: homology-based repair (homologous recombination (HR)) using the intact chromatid as a template present in proximity in S and G2 phases of the cell cycle, or direct joining across the break site (non-homologous end joining (NHEJ)). 2 The coordination between cell cycle progression and DSB repair (DSBR) is regulated by the DNA damage response (DDR) signalling pathway, which activates the cell cycle checkpoints in the presence of DNA breaks. 3 This pathway is initiated by the recruitment of the MRN (MRE11 --RAD50 --NBS1) sensor complex to sites of damage. The recruitment of MRN subsequently activates the ATM kinase, which associates with DSBs and phosphorylates the histone variant H2AX (g-H2AX).
2 MDC1 can then bind to gH2AX and recruit new MRN and ATM proteins, leading to spreading of the repair machinery along the chromosome. MDC1 also recruits ubiquitin ligases, such as RNF8 and RNF168, which facilitate the recruitment of the downstream factors 53BP1 and BRCA1. 2 When the DNA is resected to singlestranded DNA, it is recognized by replication protein A, which results in the recruitment of ATR. 2 Both the ATM and the ATR dependent branches of the pathway lead to the activation of the checkpoint kinases, CHK1 and CHK2, which stall damaged cells in their cell cycle until the lesions are resolved. 3 DNA repair, like all DNA-dependent processes, occur in the highly compartmentalized nucleus. Most nuclear events do not occur ubiquitously, but are limited to defined sites. 2 Several studies in yeast have shown that dedicated DNA repair centres exist as preferential sites of repair. 2, 4 Furthermore, persistent DSBs in yeast migrate from their internal nuclear positions to the nuclear periphery, where they associate with nuclear pores. 5, 6 This sequestration to the nuclear periphery was shown to require certain components of the yeast nuclear pore complex, like NUP84 and the nucleoporin NUP60, located in the basket of the pore. 5, 6 Additional studies revealed that depletion of representative members of the NUP84 or NUP60 complex leads to synthetic lethality when combined with genes that are required for DSBR through HR. 4 Moreover, mutants of the NUP84 complex are highly sensitive to DNA-damaging treatments. 7 A more recent study has shown that key nucleoporins are phosphorylated upon DNA damage and act to neutralize the topological tension generated at nuclear pore tethered genes that is inhibitory to origin firing after replication stress. 8 On the contrary, in mammalian cells, each DSB is repaired individually in the absence of nuclear repair centers. 9 Furthermore, DSBs do not move towards the nuclear periphery, as their motion seems to be very limited in the mammalian nucleus. 9 However, the evolutionary conserved role of nucleoporins in gene regulation raises the question whether nucleoporins have a conserved role in mammalian DSBR. We therefore explored the role of the Nucleoporin 153 (NUP153), a component of the nuclear basket of the mammalian nuclear pore in DSBR. We show that NUP153 is essential for proper activation of the DNA damage checkpoints and regulates the choice between NHEJ and HR. These functions can be partially explained by the role of NUP153 in promoting 53BP1 nuclear localization. Our results will set up the basis of investigation of the role of nuclear pore in DNA repair in mammals and can lead to potential therapeutic innovations.
RESULTS AND DISCUSSION
One of the hallmarks of defective DSBR and DDR is hypersensitivity to DNA damaging agents. To address whether the NUP153 has a role in repair of DSBs, we analysed the effect of its depletion in clonogenic survival of U2OS cells following exposure to genotoxic stress. RNAi-mediated downregulation of NUP153 led to an increased sensitivity to the radiomimetic drug phleomycin compared with control cells (Figure 1a) . The efficiency of the NUP153 silencing was verified by RT --qPCR (Supplementary Figure 1) and western blot (Figure 1b) . One possible explanation for the hypersensitivity to DNA damage upon depletion of NUP153 is the deregulation of cell cycle checkpoints resulting in mitotic progression with unrepaired DSBs. To test this hypothesis, we investigated whether the downregulation of NUP153 affects the activation of checkpoints after treatment with the radiomimetic drug Neocarzinostatin (NCS). Indeed, we observed compromised phosphorylation of ATM, CHK1 and CHK2 kinases and p53 (Figure 1b ). In line with this observation, the NUP153 depleted cells didn't properly activate the G2/M check point. Although, 31% of cells treated with si-scramble arrest in G2/M, 8 h after treatment with phleomycin, only 26% of siNUP153 cells exert similar arrest (Supplementary Figure 2) . These results support the idea that NUP153 promotes DNA damage checkpoints.
To investigate the possibility that the hypersensitivity to DNA damaging agents stems also from persistent DSBs and defective DNA repair, we sought to directly test whether NUP153 facilitates DNA repair through a specific pathway. To this end, we utilized cell lines that contain stably integrated reporters to assess the rates of HR (DR-GFP 10, 11 ) and NHEJ. 12 --14 For NHEJ, we used cell lines containing two types of NHEJ-reporter substrates; the pCOH-CD4 that permits analysis of the NHEJ of two distal ends (separated by 3.2 kb), 12, 13 and a GFP-based substrate, 14 to measure the NHEJ on closely adjacent ends, separated by only 34 bp.
14 Figure 1 . NUP153 promotes survival and is required for proper activation of DNA damage checkpoints. (a) Clonogenic survival in U2OS cells treated with the indicated siRNAs, following exposure to increasing concentrations of the radiomimetic drug phleomycin. NUP153-depleted cells exhibit hypersensitivity to phleomycin. This is one representative experiment out of three repetitions and s.d.s represent the errors from three internal triplicates of the depicted experiment. U2OS cells were transfected with scramble and NUP153-specific siRNAs, using Oligofectamine (Invitrogen, Grand Island, NY, USA) and 48 h after transfection, cells were counted and seeded in triplicates in 6-well plates (500 cells per well). The day after, cells were treated with 0-2-4-7.5-15-30 mg/ml of Phleomycin (Sigma, St Louis, MO, USA). Cells were then cultured for 11 days. Colonies were stained with 0.1% crystal violet. The coloration was dissolved in 20% acetic acid and the absorbance at 590 nm was measured by spectrophotometer. (b) NUP153-depleted cells exhibit decreased checkpoint activation as monitored by WB. Wholecell extracts were prepared from non-treated (NT) cells or cells harvested at the indicated times after release from a 15 min NCS-treatment (50 ng/ml), 72 h post transfection with the indicated siRNAs. Equal loading was controlled using the GAPDH antibody and equal expression of ATM, CHK1, CHK2 and p53 was ensured using the respective antibodies (Supplementary Figure 7) . The knock down of NUP153 was monitored using the NUP153 antibody. Signal intensities were measured using Image J, NIH, Bethesda, MD, USA.
Interestingly, upon depletion of NUP153, we observed a significant drop in efficiency of NHEJ with both substrates compared with the scramble siRNA (2 fold for the CD4 and 5 fold for the GFP) ( Figure 2a ). Concomitantly, we observed a more than two fold increase in the rate of HR (Figure 2b ). We used downregulation of RAD51 as a control and expectedly observed defective HR. Cell cycle analysis shows that the changes in NHEJ and HR rates cannot be explained by alterations in cell cycle profile upon depletion of NUP153 (Supplementary Figure 2) . These results suggest that NUP153 has a role in the balance between NHEJ and HR.
To investigate whether the increase in HR was accompanied by increased resection, we visualized and quantified replication protein A and BRCA1 foci at a single DSB to mimic the break induced in the NHEJ and HR assays. We utilized U2OS cells with stably integrated ISceI site harboring lacO operator repeats that can be visualized by GFP-lacR (lac repressor). As expected, we found that depletion of NUP153 leads to more than 2-fold increase in the number of replication protein A and BRCA1 foci in U2OS cells after expression of I-SceI (Figures 2c and d) . DSB induction was verified by the phosphorylation of H2AX at the lacO array (Supplementary Figures  3A and B) . Our results therefore suggest that NUP153 might inhibit HR by blocking resection of DSBs.
To understand the mechanism underlying the involvement of NUP153 in DDR, we first tested whether NUP153 is recruited to DSBs. We were unable to detect any accumulation of GFP-NUP153 at laser-induced breaks (Figure 3a) . We then asked whether NUP153 regulates the localization and the ability of known DDR factors to form IRIF upon Neocarzinostatin treatment in U2OS cells. Whereas depletion of NUP153 did not affect gH2AX (Figure 3b ) and MDC1 foci (Supplementary Figure 4) , it significantly inhibited focal accumulation of 53BP1 quantified by high throughput imaging (Figure 3c ). The results were validated by three independent siRNAs targeting distinct regions of NUP153 mRNA ranging from 30 --50% decrease in the number of 53BP1 foci (Figure 3c ). High-resolution imaging showed that NUP153 siRNA treated cells exerted massive and selective mislocalization of 53BP1 to the cytoplasm (Figure 3b , quantification in Figure 3d ). The remaining nuclear 53BP1 either did not accumulate in foci or formed foci localized to the nuclear periphery (Figure 3b) . Importantly, depletion of NUP153 did not affect the global levels of 53BP1 (Supplementary Figure 5) . To test whether the 53BP1 cytoplasmic localization in the absence of NUP153 is because of an accelerated export or defective nuclear retention, we repeated our experiments in the presence of leptomycin B that selectively inhibits CRM1-dependent nuclear export. 15 We observed no difference in the localization of 53BP1 or the foci formation (data not shown), suggesting that the presence of 53BP1 in the cytoplasm is due to an import defect or accelerated export through a CRM1-independent pathway. Indeed, previous work showed that depletion of NUP153 leads to import impairment of selective proteins. 16 Moreover, while we were conducting this study, Moudry et al. 17 confirmed the mislocalization of 53BP1 in NUP153 depleted cells and showed the requirement of NUP153 for 53BP1 nuclear import.
Recent studies have provided important mechanistic insights about how deficiency in 53BP1 restores HR levels in BRCA1-deficient cells by regulating the choice between HR and NHEJ. 18, 19 These studies have placed 53BP1 as a top candidate for pharmacological targeting for future breast cancer therapies. Therefore, we sought to understand whether the impairment of 53BP1 is sufficient to explain the NUP153-deficient phenotype in our DNA repair assays, to suggest NUP153 as a potential candidate for targeted cancer therapy. To this end, we performed the survival assay in cells depleted for 53BP1 or for a combination of NUP153 and 53BP1. Indeed, 53BP1 knock down recapitulated the sensitivity to phleomycin treatment and the decreased survival (Figure 4a) . Interestingly, combined 53BP1 and NUP153 depletion did not result in an additive survival defect suggesting that the radiosensitivity observed in NUP153 depleted cells is owing to the impairment in 53BP1 localization (Figure 4a ). The efficiency of 53BP1 knock down was monitored by RT --qPCR and WB (Supplementary Figure 6) . Moreover, 53BP1 was shown to promote ATM activity, 20 --22 and its depletion leads to checkpoint activation defects 23 pointing to similar dependency on 53BP1 for activation of the checkpoints.
We then assessed whether the increase in HR at NUP153 depleted cells was mediated by the 53BP1 defect. We observed a moderate (1.3 fold) increase of HR upon depletion of 53BP1 using siRNA (Figure 4b ). This effect was similar to that observed by Xie et al.
14 in a previous study. However, this increase was smaller than the one observed in NUP153 depleted cells, and the combinatorial depletion of 53BP1 and NUP153 phenocopied the HR efficiency in cells depleted for NUP153 alone (Figure 4b) .
Moreover, Guirouilh-Barbat et al. observed that 53BP1 silencing leads to a significant decrease in the frequency of end-joining, monitored with the GFP-based substrate, but has no impact on NHEJ frequencies, monitored with the CD4-based substrate (Bernard Lopez personal communication). This observation is different from our results that show that silencing of NUP153 leads to a decrease in NHEJ efficiency in both substrates (Figure 2a ), suggesting that NUP153 promotes NHEJ through a pathway that does not involve only 53BP1. Additionally, Guirouilh-Barbat et al. showed a decrease in NHEJ accuracy upon 53BP1 depletion (Bernard Lopez personal communication). To test whether NUP153 depletion recapitulates these results, we analyzed repair junctions on the pCOH-CD4 substrate after the silencing of NUP153. Surprisingly, although NUP153 depletion affects the efficiency of NHEJ, it does not promote inaccurate repair (Figure 4c ) further pointing to a role of NUP153 in NHEJ independent from 53BP1.
Taken together, our results suggest that in assays where a large amount of DSBs is induced the depletion of NUP153 phenocopies the depletion of 53BP1. On the other hand, when a single DSB is induced, the NUP153 depletion has a stronger and/or divergent phenotype. A possible explanation for this phenomenon is that the amount of protein remaining in the nucleus upon depletion of NUP153, is limited and there is active competition between the breaks for focal accumulation of 53BP1. On the other hand, when one or limited breaks are induced as it is the case with the I-SceI break at the HR and NHEJ assays, there is enough 53BP1 protein to form a repair focus. To test this hypothesis, we used the LacO-I-SceI cell line, where a break is induced at a single locus in the nucleus. Interestingly, we detected a normal recruitment of 53BP1 to I-SceI breaks upon depletion of NUP153 (Figures 4d and e) . This finding is in agreement with the observation that the recruitment of 53BP1 at endogenous foci is not impaired upon depletion of NUP153 (Figure 3c--Neocarzinostatin condition) .
The stronger effect on HR efficiency observed upon depletion of NUP153 could be explained by the loss of a potential 53BP1 modification and that the unmodified 53BP1 accumulates at the single DSB, acting as dominant negative. An alternative explanation could be that NUP153 has a role in addition to the regulation of nuclear import of 53BP1. It could promote the nuclear accumulation of a NHEJ factor and/or its recruitment to DSBs. However, silencing of classical NHEJ factors that affect the efficiency of end ligation affect the fidelity of repair as well. 13 An alternative scenario could be that NUP153 negatively regulates a protein that promotes HR. Furthermore, we can imagine that the nuclear soluble fraction of 53BP1 has a role in the regulation of the repair pathways, by sequestering certain factors away from the break. Therefore, we can speculate that upon depletion of NUP153, even if 53BP1 has still the ability to bind to DSBs, the absence of its soluble pool can impair DSBR.
Here, we describe a novel role of NUP153 in DDR and DNA repair. TPR, the binding partner of NUP153 at the nuclear basket, is phosphorylated upon DNA damage by ATM/ATR and is involved in the proper activation of G2/M and intra S check point. 24 NUP153 vs DSBR and DDR C Lemaître et al Figure 2 . NUP153 regulates the balance between NHEJ and HR. (a) NHEJ efficiencies in GC92 cells treated with the indicated siRNAs. The numbers represent values of NHEJ efficiency relative to the control. Two independent GC92 clones (GCS5 and GCV6) each bearing both the CD4-based and GFP-based substrates were used. Values represent the means and s.d of four independent experiments. The cells were first transfected with the indicated siRNAs using interferin (Polyplus, Illkirch, France) and 48 h after, they were transfected with HA-I-SceI expression vector (pCBASce) using jetPei (Polyplus). The GFP and CD4 frequencies were measured by FACS 3 days after the HA-I-SceI plasmid transfection. (b) HR efficiency in U2OS cells transfected with the indicated siRNAs. The numbers represent a fold increase of HR efficiency compared with the control. U2OS cells containing the HR reporter DR-GFP, were transfected with the indicated siRNAs and 48 h later transfected with an HA --I --SceI expression vector (pCBASce). GFP intensity was measured by FACS. The mean ± s.d.s of three experiments is shown. (c) Immunofluorescence staining of replication protein A (RPA) (red) or BRCA1 (red) at an I-SceI-induced break in U2OS19ptight13 GFPlacR cells transfected with scramble or NUP153 siRNA. The locus where the break is induced is visualized with the GFPlacR (green spot). The pictures represent the phenotype observed in the majority of the cells. U2OS19ptight13 GFPlacR cells were generated as follows: U2OS cells were transfected with a plasmid that contains an I-SceI recognition site flanked by 256 copies of the lac operator (lacO) on one side and by 96 copies of the tetracycline response element on the other side (tetO), 9, 26 and stable clones were selected (the clone used is called U2OS19). To obtain the U2OS19 ptight 13 cells, U2OS19 cells were transfected using Fugene 6 with pWHE320-HA-IsceI (that encodes for HAIsceI under a tet inducible promoter) and pWHEI46 (that encodes for the tet activator) at a ratio of 8:2. The cells were clonal selected with 800 mg/ml G418. Expression of HA-IsceI was obvious 14 h after Doxycyclin (Dox) treatment. The U2OS19 ptight13 GFPlacR cell line that stably expresses the lac repressor (lacR) fused to GFP, was generated by retroviral infection of MSCV-GFP-lacR plasmid. 27 The cells were FACS sorted and GFP positive cells were retained in red phenol free medium, 10% charcoal treated fetal calf serum, 800 mg/ml G418, 2 mM IPTG to avoid the permanent binding of lac repressor to the lacO. 27 For the experiment, U2OS19ptight13 GFPlacR cells were transfected with the indicated siRNAs using oligofectamine, in absence of IPTG. Cells were harvested 72 h after the transfection and 14 h after Dox treatment. One interesting aspect for further investigation is whether these factors have distinct or overlapping roles in DDR and whether the overlapping roles are mediated through their interaction. In yeast, the nucleoporin complexes NUP84 (hNUP107) and NUP60 (hNUP153) protect against genomic instability through maintenance of proper levels of the sumo protease Ulp1 at NPCs, and through appropriate sumoylation of several proteins, including yKu. 25 It is tempting to speculate that a similar mechanism is conserved in mammals. Furthermore, it would be very interesting to investigate whether the role of NUP153 in DDR is unique or if other mammalian nucleoporins have similar role.
We show here that NUP153 regulates the choice between NHEJ and HR. This observation positions NUP153 as a candidate gene whose reduced expression could promote synthetic lethality in tumor cells that bear mutations in HR factors, like BRCA1 and BRCA2. However, as NUP153 promotes 53BP1 IRIF foci formation after DNA damage, impairment of NUP153 in BRCA1 cancer cells could mimic the phenotype of 53BP1 depletion, rescuing lethality and conferring resistance to PARP inhibition. 18, 19 It will be consequently very interesting to exploit in the future the potential of NUP153 as a therapeutic target in certain cancers. were subjected to laser micro-irradiation using a 800-nm laser and subsequent real time recording of protein assembly at the damaged area. Although MDC1 accumulates efficiently at the sites of damage, recruitment of NUP153 was not detected using the same conditions. U2OS cells were transienlty transfected with 2 mg of the indicated plasmids using Fugene 6 according to the manufacturers' recommendations. (b) Immunofluorescence analysis of gH2AX (green) and 53BP1 (green) in control cells and cells treated with siRNA targeting NUP153 at non-treated (-NCS) conditions or 2 h after treatment with the radiomimetic drug NCS ( þ NCS 2 h). Cells grown on coverslips were fixed with 4% paraformaldehyde, washed with 1XPBS, permeabilized with 0.5% Triton X-100/PBS and blocked with 5% BSA/PBS before incubation with primary antibodies for 1 h in RT. After three washes with 1XPBS, cells were stained with Alexa488--conjugated secondary antibodies (Invitrogen). The nuclei were counterstained with DAPI and the samples were mounted in Prolong Gold (Invitrogen). (c) Quantification of 53BP1 foci 2 h after NCS treatment in control cells and cells treated with a pool of four siRNAs or three individual siRNAs targeting NUP153. Cells seeded at 96-well plated were trasnfected with the indicated siRNAs and stained with the indicated antibodies. High content analysis was performed using the InCELL1000 Analyzer workstation and the InCELL Analyzer software for image data processing (GE LifeSciences, Munich, Germany). To quantify the distance from the negative control, we determined the percents of control that reflects the deviation from the negative control. After multiple testing corrections, the P-values were determined. ***Po0.0001. (d) Quantification of 53BP1 intensity in the nucleus and cytoplasm of control cells and cells treated with NUP153 siRNAs. The effect of gene silencing on 53BP1 nuclear and cytoplasmic localization was investigated by immunofluorescence as described above. Image data-processing protocols (InCELL Analyzer software) were specifically developed to quantify 53BP1 foci in the nucleus and cytoplasm. ***Po0.0001. 
